Global Androstenedione Market Growth 2023-2029

Global Androstenedione Market Growth 2023-2029

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.

Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

In the report, the data bases on androstenedione and androstadienedione.

LPI (LP Information)' newest research report, the “Androstenedione Industry Forecast” looks at past sales and reviews total world Androstenedione sales in 2022, providing a comprehensive analysis by region and market sector of projected Androstenedione sales for 2023 through 2029. With Androstenedione sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androstenedione industry.

This Insight Report provides a comprehensive analysis of the global Androstenedione landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androstenedione portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Androstenedione market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androstenedione and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androstenedione.

The global Androstenedione market size is projected to grow from US$ 195.6 million in 2022 to US$ 239 million in 2029; it is expected to grow at a CAGR of 239 from 2023 to 2029.

Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.

China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.

This report presents a comprehensive overview, market shares, and growth opportunities of Androstenedione market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Androstenedione

Androstadienedione

Segmentation by application

Arthritis Pharmaceuticals

Fertility Control Pharmaceuticals

Infectious Inflammation Pharmaceuticals

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

BIOVET

Indo Phyto Chemicals

Sito Bio

Goto Pharmaceutical

Tianjin King York

Jiufu

Yongning Pharma

Jiangxi Hongyuan Pharmaceutical

Kaizon

Xi’an Gaoyuan Bio-Chem

Dongyao Pharmaceutical

Huazhong Pharmaceutical

Darui

Danjiangkou Danao

Dahua Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Androstenedione market?

What factors are driving Androstenedione market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Androstenedione market opportunities vary by end market size?

How does Androstenedione break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.